BioSpace News Archive

This year M100 is available as part of a package with either M02 or M07, or all three documents together.

At Neuroscience 2017, a new imaging mode for the ZEISS LSM 8 family with Airyscan has been introduced.

Portage Biotech is pleased to announce that it has completed the distribution of shares of Biohaven Pharma to all eligible Portage shareholders.

The Annual Report on Form 10-K contains information pertaining to the Company’s interim quarterly, year-to-date and annual results for 2016 and 2015.

An analysis of patients with newly diagnosed, locally advanced pancreatic cancer treated with up to 6 cycles of ABRAXANE + gemcitabine as an investigational induction therapy (n=106) found that patients had a median time to treatment failure (TTF) of 8.8 months (90% CI: 6.67-9.82), which exceeded the protocol-specified target of 6.6 months (primary endpoint).

Magno-Humphries Laboratories, Inc., is voluntarily recalling one lot of Basic Drugs Brand of Senna Laxative tablets, 8.6mg Sennosides to the consumer level due to a customer complaint that their bottle labeled as Senna Laxative actually contained Basic Drugs Brand of Naproxen Sodium 220mg.

All of the recent problems have caused the company’s largest shareholder to push for a sale.

The cuts are being made as the company grapples with a debt of between $30 and $35B and a restructuring of its R&D in order to combat dramatically declining revenue from its generic pipeline.

This little-known hedge fund that has a focus on biotech and the life sciences beat out a couple of the heavy-hitters, David Einhorn and Bill Ackman.

Shire will have its new CFO in March.